Structural Analysis of Botulinum Neurotoxin Type E Catalytic Domain and Its Mutant Glu212→Gln Reveals the Pivotal Role of the Glu212 Carboxylate in the Catalytic Pathway (original) (raw)

Abstract

Botulinum neurotoxin (BoNT) binds peripheral neurons at the neuromuscular junction through a dual-receptor mechanism that includes interactions with ganglioside and protein receptors. The receptor identities vary depending on BoNT serotype (A-G). BoNT/B and BoNT/G bind the luminal domains of synaptotagmin I and II, homologous synaptic vesicle proteins. We observe conditions under which BoNT/B binds both Syt isoforms, but BoNT/G binds only SytI. Both serotypes bind ganglioside G T1b. The BoNT/G receptor-binding domain crystal structure provides a context for examining these binding interactions and a platform for understanding the physiological relevance of different Syt receptor isoforms in vivo.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (22)

  1. Simpson, L. L. (1981) The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol. Rev. 33, 155-188.
  2. Gill, D. M. (1982) Bacterial toxins: A table of lethal amounts. Microbiol. Rev. 46, 86-94.
  3. Brunger, A. T., Jin, R., and Breidenbach, M. A. (2008) Highly specific interactions between botulinum neurotoxins and synaptic vesicle proteins. Cell. Mol. Life Sci. 65, 2296-2306.
  4. Montecucco, C., Papini, E., and Schiavo, G. (1994) Bacterial protein toxins penetrate cells via a four-step mechanism. FEBS Lett. 346, 92-98.
  5. Montecucco, C. (1986) How do tetanus and botulinum neurotoxins bind to neuronal membranes? Trends Biochem. Sci. 11, 314-317.
  6. Kitamura, M., Iwamori, M., and Nagai, Y. (1980) Interaction between Clostridium botulinum neurotoxin and gangliosides. Biochim. Biophys. Acta 628, 328-335.
  7. Dong, M., Richards, D. A., Goodnough, M. C., Tepp, W. H., Johnson, E. A., and Chapman, E. R. (2003) Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J. Cell Biol. 162, 1293-1303.
  8. Rummel, A., Karnath, T., Henke, T., Bigalke, H., and Binz, T. (2004) Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J. Biol. Chem. 279, 30865-30870.
  9. Rummel, A., Eichner, T., Weil, T., Karnath, T., Gutcaits, A., Mahr- hold, S., Sandhoff, K., Proia, R. L., Acharya, K. R., Bigalke, H., and Binz, T. (2007) Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept. Proc. Natl. Acad. Sci. U.S.A. 104, 359-364.
  10. Sudhof, T. C. (2004) The synaptic vesicle cycle. Annu. Rev. Neurosci. 27, 509-547.
  11. Baldwin, M. R., Tepp, W. H., Przedpelski, A., Pier, C. L., Bradshaw, M., Johnson, E. A., and Barbieri, J. T. (2008) Subunit vaccine against the seven serotypes of botulism. Infect. Immun. 76, 1314-1318.
  12. Otwinowski, Z., and Minor, W. (1997) Processing of X-ray diffraction data collected in oscillation mode. Macromol. Crystallogr. 276 (Part A), 307-326.
  13. Swaminathan, S., and Eswaramoorthy, S. (2000) Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat. Struct. Biol. 7, 693-699.
  14. Vagin, A., and Teplyakov, A. (1997) MOLREP: An automated program for molecular replacement. J. Appl. Crystallogr. 30, 1022-1025.
  15. Emsley, P., and Cowtan, K. (2004) Coot: Model-building tools for molecular graphics. Acta Crystallogr. D60, 2126-2132.
  16. Adams, P. D., Grosse-Kunstleve, R. W., Hung, L. W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., and Terwilliger, T. C. (2002) PHENIX: Building new software for automated crystallographic structure determination. Acta Crys- tallogr. D58, 1948-1954.
  17. Painter, J., and Merritt, E. A. (2006) Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr. D62, 439-450.
  18. Painter, J., and Merritt, E. A. (2005) A molecular viewer for the analysis of TLS rigid-body motion in macromolecules. Acta Crystal- logr. D61, 465-471.
  19. Stenmark, P., Dupuy, J., Imamura, A., Kiso, M., and Stevens, R. C. (2008) Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin-neuron interaction. PLoS Pathog. 4, e1000129.
  20. Stenmark, P., Dong, M., Dupuy, J., Chapman, E. R., and Stevens, R. C. (2010) Crystal structure of the botulinum neurotoxin type G binding domain: Insight into cell surface binding. J. Mol. Biol. 397, 1287-1297.
  21. Jin, R., Rummel, A., Binz, T., and Brunger, A. T. (2006) Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity. Nature 444, 1092-1095.
  22. Chai, Q., Arndt, J. W., Dong, M., Tepp, W. H., Johnson, E. A., Chapman, E. R., and Stevens, R. C. (2006) Structural basis of cell surface receptor recognition by botulinum neurotoxin B. Nature 444, 1096-1100.